In 2007, Mehmet Toner and Daniel Haber and their collaborators at Massachusetts General Hospital and Harvard Medical School developed a microfluidic device capable of trapping rare circulating tumor cells from the blood of cancer patients.
Microfluidic device capable of trapping rare circulating tumor cells from blood of cancer patients